Autologous memory lymphocyte(Newish)

自体记忆性淋巴细胞

Report date: 2025/10/14 20:00:08

Base Information

Drug NameAutologous memory lymphocyte(Newish)

Drug Alias Nameautologous Tcm cellular therapy(Newish)Autologous Tcm Cellulartherapy(Newish)NewishT

ClassificationCell and gene therapy > Cell therapy > Donor > AutologousCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Memory T cell therapy

Mechanisms of ActionImmunostimulantsT lymphocyte replacements

TargetsNot applicable

Therapy Area/IndicationsCarcinoma, Hepatocellular

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaPhase 2 Clinical

Originator CompaniesNewish Technology (Beijing) Co Ltd

China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesNewish Technology (Beijing) Co Ltd

Inactive CompaniesN/A

Active IndicationsCarcinoma, Hepatocellular

Inactive IndicationsN/A

Other Information

ATC CodeN/A